Are you using the same columns for purifying both WT and mutant? Could you have 
the tiniest fraction of WT contaminating your mutant batches which would then 
turnover you substrate in crystallo over the couple of weeks? You could try 
washing the columns/systems with NaOH or pepsin to remove WT, or just use 
separate columns. 

Dan

Daniel A Bonsor PhD.
Sundberg Lab
Institute of Human Virology
University of Maryland, Baltimore
725 W Lombard Street N370
Baltimore
Maryland
MD 21201
Tel: (410) 706-7457



-----Original Message-----
From: CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] On Behalf Of Pierre 
Nioche
Sent: Thursday, April 13, 2017 11:28 AM
To: CCP4BB@JISCMAIL.AC.UK
Subject: [ccp4bb] in crystallo enzymatic activity

Dear CCP4bb,

We work on an enzyme that we crystallized with two substrates bound in the 
active site (the reaction transform two substrates into two products). We have 
also the structure with the two products. We are able to see densities for the 
substrates when we collect data at different time point post-crystallization 
(days or weeks later). There is no change over time and no in crystallo 
enzymatic reaction despite the fact that in solution using the same 
crystallization solution, the reaction occurs readily.
This is not surprising and there are already many examples in the literature.
However, when we crystallize a single amino acid variant (mutant within the 
active site) with the same two substrates, we initially see the substrates but 
we then observe in crystallo enzymatic activity and formation of the final 
products over time. This structure is identical to the one determined with the 
two products co-crystallized with the enzyme. The crystal packing does not seem 
to be at play here.
I understand that in crystallo activities are well documented in the literature 
and can be induced by addition of ligands, X-rays, change in oxidative 
environment, etc?
Here, the substrates are present from the beginning of the crystallization 
experiments with the same concentration. Nothing is added to the crystals later 
on. Only the time differentiate the two type of crystals: after a couple of 
weeks, one has the substrates in the active site (wt) while the other has the 
products (variant).

Is anyone aware of similar examples where a variant induce in crystallo 
enzymatic activity without perturbation of the crystal?

Thanks,

Pierre
Dept of Pharmacology, Toxicology and cellular signaling Paris Descartes 
University

Reply via email to